{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:43:25Z","timestamp":1765961005532,"version":"3.37.3"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00467-017-3744-y","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T18:15:56Z","timestamp":1501092956000},"page":"1297-1307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of von Willebrand factor in thrombotic microangiopathy"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3385-6174","authenticated-orcid":false,"given":"Damien G.","family":"Noone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Licht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"key":"3744_CR1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-0031-1297375","volume":"37","author":"HC Kwaan","year":"2011","unstructured":"Kwaan HC (2011) Microvascular thrombosis: a serious and deadly pathologic process in multiple diseases. Semin Thromb Hemost 37:961\u2013978","journal-title":"Semin Thromb Hemost"},{"key":"3744_CR2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654\u2013666","journal-title":"N Engl J Med"},{"key":"3744_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.blre.2014.01.003","volume":"28","author":"SR Cataland","year":"2014","unstructured":"Cataland SR, Wu HM (2014) Diagnosis and management of complement mediated thrombotic microangiopathies. Blood Rev 28:67\u201374","journal-title":"Blood Rev"},{"key":"3744_CR4","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood-2013-04-496752","volume":"122","author":"CC Deford","year":"2013","unstructured":"Deford CC, Reese JA, Schwartz LH, Perdue JJ, Kremer Hovinga JA, Lammle B, Terrell DR, Vesely SK, George JN (2013) Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood 122:2023\u20132029, quiz 2142","journal-title":"Blood"},{"key":"3744_CR5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1525-139X.2011.01035.x","volume":"25","author":"WF Clark","year":"2012","unstructured":"Clark WF (2012) Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange. Semin Dial 25:214\u2013219","journal-title":"Semin Dial"},{"key":"3744_CR6","doi-asserted-by":"crossref","first-page":"310596","DOI":"10.5402\/2012\/310596","volume":"2012","author":"M Radhi","year":"2012","unstructured":"Radhi M, Carpenter SL (2012) Thrombotic microangiopathies. ISRN Hematol 2012:310596","journal-title":"ISRN Hematol"},{"key":"3744_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0034-1376521","volume":"40","author":"M Riedl","year":"2014","unstructured":"Riedl M, Orth-Holler D, Wurzner R (2014) An update on the thrombotic microangiopathies hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Semin Thromb Hemost 40:413\u2013415","journal-title":"Semin Thromb Hemost"},{"key":"3744_CR8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0034-1376153","volume":"40","author":"M Riedl","year":"2014","unstructured":"Riedl M, Fakhouri F, Le Quintrec M, Noone DG, Jungraithmayr TC, Fremeaux-Bacchi V, Licht C (2014) Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 40:444\u2013464","journal-title":"Semin Thromb Hemost"},{"key":"3744_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajmg.10499","volume":"111","author":"JL Hove Van","year":"2002","unstructured":"Van Hove JL, Van Damme-Lombaerts R, Grunewald S, Peters H, Van Damme B, Fryns JP, Arnout J, Wevers R, Baumgartner ER, Fowler B (2002) Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy. Am J Med Genet 111:195\u2013201","journal-title":"Am J Med Genet"},{"key":"3744_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM (2009) Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 361:345\u2013357","journal-title":"N Engl J Med"},{"key":"3744_CR11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire M, Fremeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, Nurnberg G, Altmuller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, Nurnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP (2013) Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet 45:531\u2013536","journal-title":"Nat Genet"},{"key":"3744_CR12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0272-6386(97)90143-8","volume":"29","author":"BW Miller","year":"1997","unstructured":"Miller BW, Hmiel SP, Schnitzler MA, Brennan DC (1997) Cyclosporine as cause of thrombotic microangiopathy after renal transplantation. Am J Kidney Dis 29:813\u2013814","journal-title":"Am J Kidney Dis"},{"key":"3744_CR13","doi-asserted-by":"crossref","unstructured":"Kojouri K, Vesely SK, George JN (2001) Quinine-associated thrombotic thrombocytopenic purpura\u2013hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med 135:1047\u20131051","DOI":"10.7326\/0003-4819-135-12-200112180-00008"},{"issue":"Suppl 2","key":"3744_CR14","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0049-3848(09)70012-X","volume":"123","author":"A D\u2019Angelo","year":"2009","unstructured":"D\u2019Angelo A, Fattorini A, Crippa L (2009) Thrombotic microangiopathy in pregnancy. Thromb Res 123[Suppl 2]:S56\u2013S62","journal-title":"Thromb Res"},{"key":"3744_CR15","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/j.1600-6143.2012.04124.x","volume":"12","author":"D Noone","year":"2012","unstructured":"Noone D, Al-Matrafi J, Tinckam K, Zipfel PF, Herzenberg AM, Thorner PS, Pluthero FG, Kahr WH, Filler G, Hebert D, Harvey E, Licht C (2012) Antibody mediated rejection associated with complement factor H-related protein 3\/1 deficiency successfully treated with eculizumab. Am J Transplant 12:2546\u20132553","journal-title":"Am J Transplant"},{"key":"3744_CR16","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","volume":"10","author":"AA Satoskar","year":"2010","unstructured":"Satoskar AA, Pelletier R, Adams P, Nadasdy GM, Brodsky S, Pesavento T, Henry M, Nadasdy T (2010) De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection. Am J Transplant 10:1804\u20131811","journal-title":"Am J Transplant"},{"key":"3744_CR17","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","volume":"122","author":"S Jodele","year":"2013","unstructured":"Jodele S, Licht C, Goebel J, Dixon BP, Zhang K, Sivakumaran TA, Davies SM, Pluthero FG, Lu L, Laskin BL (2013) Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood 122:2003\u20132007","journal-title":"Blood"},{"key":"3744_CR18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","volume":"20","author":"S Jodele","year":"2014","unstructured":"Jodele S, Fukuda T, Vinks A, Mizuno K, Laskin BL, Goebel J, Dixon BP, Teusink A, Pluthero FG, Lu L, Licht C, Davies SM (2014) Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 20:518\u2013525","journal-title":"Biol Blood Marrow Transplant"},{"key":"3744_CR19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.2.4790.897","volume":"2","author":"WS Symmers","year":"1952","unstructured":"Symmers WS (1952) Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). Br Med J 2:897\u2013903","journal-title":"Br Med J"},{"key":"3744_CR20","first-page":"21","volume":"24","author":"E Moschcowitz","year":"1924","unstructured":"Moschcowitz E (1924) Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc 24:21\u201324","journal-title":"Proc NY Pathol Soc"},{"key":"3744_CR21","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","volume":"307","author":"JL Moake","year":"1982","unstructured":"Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D (1982) Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432\u20131435","journal-title":"N Engl J Med"},{"key":"3744_CR22","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","volume":"339","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578\u20131584","journal-title":"N Engl J Med"},{"key":"3744_CR23","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"HM Tsai","year":"1998","unstructured":"Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585\u20131594","journal-title":"N Engl J Med"},{"key":"3744_CR24","first-page":"368","volume":"300","author":"S Rennard","year":"1979","unstructured":"Rennard S, Abe S (1979) Decreased cold-insoluble globulin in congenital thrombocytopenia (Upshaw-Schulman syndrome). N Engl J Med 300:368","journal-title":"N Engl J Med"},{"key":"3744_CR25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1160\/TH11-11-0799","volume":"107","author":"F Taguchi","year":"2012","unstructured":"Taguchi F, Yagi H, Matsumoto M, Sadamura S, Isonishi A, Soejima K, Fujimura Y (2012) The homozygous p.C1024R- ADAMTS13 gene mutation links to a late-onset phenotype of Upshaw-Schulman syndrome in Japan. Thromb Haemost 107:1003\u20131005","journal-title":"Thromb Haemost"},{"key":"3744_CR26","doi-asserted-by":"crossref","unstructured":"Moatti-Cohen M, Garrec C, Wolf M, Boisseau P, Galicier L, Azoulay E, Stepanian A, Delmas Y, Rondeau E, Bezieau S, Coppo P, Veyradier A (2012) Unexpected frequency of Upshaw\u2013Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura. Blood 119:5888\u20135897","DOI":"10.1182\/blood-2012-02-408914"},{"key":"3744_CR27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2012.09.006","volume":"126","author":"HM Tsai","year":"2013","unstructured":"Tsai HM (2013) Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome. Am J Med 126:200\u2013209","journal-title":"Am J Med"},{"key":"3744_CR28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02982558","volume":"74","author":"S Kinoshita","year":"2001","unstructured":"Kinoshita S, Yoshioka A, Park YD, Ishizashi H, Konno M, Funato M, Matsui T, Titani K, Yagi H, Matsumoto M, Fujimura Y (2001) Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura. Int J Hematol 74:101\u2013108","journal-title":"Int J Hematol"},{"key":"3744_CR29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02982559","volume":"74","author":"Y Sasahara","year":"2001","unstructured":"Sasahara Y, Kumaki S, Ohashi Y, Minegishi M, Kano H, Bessho F, Tsuchiya S (2001) Deficient activity of von Willebrand factor-cleaving protease in patients with Upshaw-Schulman syndrome. Int J Hematol 74:109\u2013114","journal-title":"Int J Hematol"},{"key":"3744_CR30","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","volume":"276","author":"X Zheng","year":"2001","unstructured":"Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K (2001) Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276:41059\u201341063","journal-title":"J Biol Chem"},{"key":"3744_CR31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488\u2013494","journal-title":"Nature"},{"key":"3744_CR32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0034-1376883","volume":"40","author":"P Knobl","year":"2014","unstructured":"Knobl P (2014) Inherited and acquired thrombotic thrombocytopenic purpura (TTP) in adults. Semin Thromb Hemost 40:493\u2013502","journal-title":"Semin Thromb Hemost"},{"key":"3744_CR33","first-page":"1073","volume":"365","author":"PI Tarr","year":"2005","unstructured":"Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073\u20131086","journal-title":"Lancet"},{"key":"3744_CR34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(83)91795-6","volume":"1","author":"MA Karmali","year":"1983","unstructured":"Karmali MA, Steele BT, Petric M, Lim C (1983) Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1:619\u2013620","journal-title":"Lancet"},{"key":"3744_CR35","first-page":"905","volume":"20","author":"C Gasser","year":"1955","unstructured":"Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) Hemolytic\u2013uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr 20:905\u2013909","journal-title":"Schweiz Med Wochenschr"},{"key":"3744_CR36","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","volume":"23","author":"J Scheiring","year":"2008","unstructured":"Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 23:1749\u20131760","journal-title":"Pediatr Nephrol"},{"key":"3744_CR37","first-page":"495","volume":"8","author":"BS Kaplan","year":"1977","unstructured":"Kaplan BS (1977) Hemolytic uremic syndrome with recurrent episodes: an important subset. Clin Nephrol 8:495\u2013498","journal-title":"Clin Nephrol"},{"key":"3744_CR38","first-page":"162","volume":"6","author":"MC Brain","year":"1969","unstructured":"Brain MC (1969) The haemolytic-uraemic syndrome. Semin Hematol 6:162\u2013180","journal-title":"Semin Hematol"},{"key":"3744_CR39","doi-asserted-by":"crossref","unstructured":"Hagge WW, Holley KE, Burke EC, Stickler GB (1967) Hemolytic\u2013uremic syndrome in two siblings. N Engl J Med 277:138\u2013139","DOI":"10.1056\/NEJM196707202770306"},{"key":"3744_CR40","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM197505222922102","volume":"292","author":"BS Kaplan","year":"1975","unstructured":"Kaplan BS, Chesney RW, Drummond KN (1975) Hemolytic uremic syndrome in families. N Engl J Med 292:1090\u20131093","journal-title":"N Engl J Med"},{"key":"3744_CR41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.1981.03310310044021","volume":"245","author":"L Carreras","year":"1981","unstructured":"Carreras L, Romero R, Requesens C, Oliver AJ, Carrera M, Clavo M, Alsina J (1981) Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3,B7 haplotype. JAMA 245:602\u2013604","journal-title":"JAMA"},{"key":"3744_CR42","first-page":"68","volume":"4","author":"A Drukker","year":"1975","unstructured":"Drukker A, Winterborn M, Bennett B, Churg J, Spitzer A, Greifer I (1975) Recurrent hemolytic-uremic syndrome: a case report. Clin Nephrol 4:68\u201372","journal-title":"Clin Nephrol"},{"key":"3744_CR43","first-page":"357","volume":"101","author":"P Barre","year":"1977","unstructured":"Barre P, Kaplan BS, de Chadarevian JP, Drummond KN (1977) Hemolytic uremic syndrome with hypocomplementemia, serum C3NeF, and glomerular deposits of C3. Arch Pathol Lab Med 101:357\u2013361","journal-title":"Arch Pathol Lab Med"},{"key":"3744_CR44","first-page":"110","volume":"46","author":"RA Thompson","year":"1981","unstructured":"Thompson RA, Winterborn MH (1981) Hypocomplementaemia due to a genetic deficiency of beta 1H globulin. Clin Exp Immunol 46:110\u2013119","journal-title":"Clin Exp Immunol"},{"key":"3744_CR45","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0272-6386(12)81065-1","volume":"24","author":"V Pichette","year":"1994","unstructured":"Pichette V, Querin S, Schurch W, Brun G, Lehner-Netsch G, Delage JM (1994) Familial hemolytic-uremic syndrome and homozygous factor H deficiency. Am J Kidney Dis 24:936\u2013941","journal-title":"Am J Kidney Dis"},{"key":"3744_CR46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","volume":"53","author":"P Warwicker","year":"1998","unstructured":"Warwicker P, Goodship TH, Donne RL, Pirson Y, Nicholls A, Ward RM, Turnpenny P, Goodship JA (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53:836\u2013844","journal-title":"Kidney Int"},{"key":"3744_CR47","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/ndt\/14.5.1229","volume":"14","author":"P Warwicker","year":"1999","unstructured":"Warwicker P, Donne RL, Goodship JA, Goodship TH, Howie AJ, Kumararatne DS, Thompson RA, Taylor CM (1999) Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency. Nephrol Dial Transplant 14:1229\u20131233","journal-title":"Nephrol Dial Transplant"},{"key":"3744_CR48","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/ndt\/13.8.1921","volume":"13","author":"P Warwicker","year":"1998","unstructured":"Warwicker P, Goodship JA, Goodship TH (1998) Factor H\u2014US? Nephrol Dial Transplant 13:1921\u20131923","journal-title":"Nephrol Dial Transplant"},{"key":"3744_CR49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00467-013-2654-x","volume":"29","author":"D Noone","year":"2014","unstructured":"Noone D, Waters A, Pluthero FG, Geary DF, Kirschfink M, Zipfel PF, Licht C (2014) Successful treatment of DEAP-HUS with eculizumab. Pediatr Nephrol 29:841\u2013851","journal-title":"Pediatr Nephrol"},{"key":"3744_CR50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jth.12826","volume":"13","author":"L Zafrani","year":"2015","unstructured":"Zafrani L, Mariotte E, Darmon M, Canet E, Merceron S, Boutboul D, Veyradier A, Galicier L, Azoulay E (2015) Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity. J Thromb Haemost 13:380\u2013389","journal-title":"J Thromb Haemost"},{"key":"3744_CR51","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","volume":"115","author":"JA Kremer Hovinga","year":"2010","unstructured":"Kremer Hovinga JA, Vesely SK, Terrell DR, Lammle B, George JN (2010) Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 115:1500\u20131511, quiz 1662","journal-title":"Blood"},{"key":"3744_CR52","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/jth.13016","volume":"13","author":"L Zafrani","year":"2015","unstructured":"Zafrani L, Azoulay E (2015) Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity: reply. J Thromb Haemost 13:1526\u20131527","journal-title":"J Thromb Haemost"},{"key":"3744_CR53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","volume":"102","author":"SK Vesely","year":"2003","unstructured":"Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El-Harake MA, Raskob GE (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102:60\u201368","journal-title":"Blood"},{"key":"3744_CR54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/asheducation-2015.1.631","volume":"2015","author":"JE Sadler","year":"2015","unstructured":"Sadler JE (2015) What\u2019s new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura. Hematol Am Soc Hematol Educ Program 2015:631\u2013636","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3744_CR55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","volume":"129","author":"K Kokame","year":"2005","unstructured":"Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T (2005) FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 129:93\u2013100","journal-title":"Br J Haematol"},{"key":"3744_CR56","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","volume":"46","author":"S Kato","year":"2006","unstructured":"Kato S, Matsumoto M, Matsuyama T, Isonishi A, Hiura H, Fujimura Y (2006) Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion 46:1444\u20131452","journal-title":"Transfusion"},{"key":"3744_CR57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Fr\u00e9meaux-Bacchi V, HUS International (2016) An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 31:15\u201339","journal-title":"Pediatr Nephrol"},{"key":"3744_CR58","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2012-07-442285","volume":"121","author":"K Ceunynck De","year":"2013","unstructured":"De Ceunynck K, De Meyer SF, Vanhoorelbeke K (2013) Unwinding the von Willebrand factor strings puzzle. Blood 121:270\u2013277","journal-title":"Blood"},{"issue":"Suppl 1","key":"3744_CR59","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jth.12225","volume":"11","author":"T Nightingale","year":"2013","unstructured":"Nightingale T, Cutler D (2013) The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story. J Thromb Haemost 11[Suppl 1]:192\u2013201","journal-title":"J Thromb Haemost"},{"key":"3744_CR60","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1182\/blood-2007-09-113746","volume":"111","author":"V Babich","year":"2008","unstructured":"Babich V, Meli A, Knipe L, Dempster JE, Skehel P, Hannah MJ, Carter T (2008) Selective release of molecules from Weibel-Palade bodies during a lingering kiss. Blood 111:5282\u20135290","journal-title":"Blood"},{"key":"3744_CR61","doi-asserted-by":"crossref","first-page":"36361","DOI":"10.1074\/jbc.M111.271890","volume":"286","author":"K Ceunynck De","year":"2011","unstructured":"De Ceunynck K, Rocha S, Feys HB, De Meyer SF, Uji-i H, Deckmyn H, Hofkens J, Vanhoorelbeke K (2011) Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis. J Biol Chem 286:36361\u201336367","journal-title":"J Biol Chem"},{"key":"3744_CR62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0031-1300950","volume":"38","author":"N Turner","year":"2012","unstructured":"Turner N, Nolasco L, Moake J (2012) Generation and breakdown of soluble ultralarge von Willebrand factor multimers. Semin Thromb Hemost 38:38\u201346","journal-title":"Semin Thromb Hemost"},{"key":"3744_CR63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1538-7836.2008.03209.x","volume":"7","author":"N Turner","year":"2009","unstructured":"Turner N, Nolasco L, Dong JF, Moake J (2009) ADAMTS-13 cleaves long von Willebrand factor multimeric strings anchored to endothelial cells in the absence of flow, platelets or conformation-altering chemicals. J Thromb Haemost 7:229\u2013232","journal-title":"J Thromb Haemost"},{"key":"3744_CR64","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1073\/pnas.0608422104","volume":"104","author":"SW Schneider","year":"2007","unstructured":"Schneider SW, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, Netz RR, Schneider MF (2007) Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci USA 104:7899\u20137903","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"3744_CR65","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.thromres.2007.03.011","volume":"120","author":"ZM Ruggeri","year":"2007","unstructured":"Ruggeri ZM (2007) The role of von Willebrand factor in thrombus formation. Thromb Res 120[Suppl 1]:S5\u2013S9","journal-title":"Thromb Res"},{"key":"3744_CR66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jth.12160","volume":"11","author":"KM Valentijn","year":"2013","unstructured":"Valentijn KM, Eikenboom J (2013) Weibel-Palade bodies: a window to von Willebrand disease. J Thromb Haemost 11:581\u2013592","journal-title":"J Thromb Haemost"},{"key":"3744_CR67","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","volume":"87","author":"HM Tsai","year":"1996","unstructured":"Tsai HM (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87:4235\u20134244","journal-title":"Blood"},{"key":"3744_CR68","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","volume":"87","author":"M Furlan","year":"1996","unstructured":"Furlan M, Robles R, Lammle B (1996) Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87:4223\u20134234","journal-title":"Blood"},{"key":"3744_CR69","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1538-7836.2005.01360.x","volume":"3","author":"JF Dong","year":"2005","unstructured":"Dong JF (2005) Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J Thromb Haemost 3:1710\u20131716","journal-title":"J Thromb Haemost"},{"key":"3744_CR70","doi-asserted-by":"crossref","first-page":"29633","DOI":"10.1074\/jbc.M301385200","volume":"278","author":"JF Dong","year":"2003","unstructured":"Dong JF, Moake JL, Bernardo A, Fujikawa K, Ball C, Nolasco L, Lopez JA, Cruz MA (2003) ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. J Biol Chem 278:29633\u201329639","journal-title":"J Biol Chem"},{"key":"3744_CR71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2003.10.004","volume":"41","author":"JA Lopez","year":"2004","unstructured":"Lopez JA, Dong JF (2004) Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells. Semin Hematol 41:15\u201323","journal-title":"Semin Hematol"},{"key":"3744_CR72","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-12-385504-6.00003-8","volume":"99","author":"S Lancellotti","year":"2011","unstructured":"Lancellotti S, De Cristofaro R (2011) Structure and proteolytic properties of ADAMTS13, a metalloprotease involved in the pathogenesis of thrombotic microangiopathies. Prog Mol Biol Transl Sci 99:105\u2013144","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3744_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12185-009-0476-1","volume":"91","author":"HM Tsai","year":"2010","unstructured":"Tsai HM (2010) Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol 91:1\u201319","journal-title":"Int J Hematol"},{"key":"3744_CR74","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1160\/TH06-02-0100","volume":"95","author":"HM Tsai","year":"2006","unstructured":"Tsai HM, Raoufi M, Zhou W, Guinto E, Grafos N, Ranzurmal S, Greenfield RS, Rand JH (2006) ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura. Thromb Haemost 95:886\u2013892","journal-title":"Thromb Haemost"},{"key":"3744_CR75","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2009-05-199208","volume":"114","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Conway EM (2009) Coagulation and innate immune responses: can we view them separately? Blood 114:2367\u20132374","journal-title":"Blood"},{"key":"3744_CR76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","volume":"34","author":"K Oikonomopoulou","year":"2012","unstructured":"Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD (2012) Interactions between coagulation and complement\u2014their role in inflammation. Semin Immunopathol 34:151\u2013165","journal-title":"Semin Immunopathol"},{"key":"3744_CR77","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","volume":"28","author":"MM Markiewski","year":"2007","unstructured":"Markiewski MM, Nilsson B, Nilsson Ekdahl K, Mollnes TE, Lambris JD (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28:184\u2013192","journal-title":"Trends Immunol"},{"issue":"Suppl 1","key":"3744_CR78","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1111\/jth.12950","volume":"13","author":"EM Conway","year":"2015","unstructured":"Conway EM (2015) Reincarnation of ancient links between coagulation and complement. J Thromb Haemost 13[Suppl 1]:S121\u2013S132","journal-title":"J Thromb Haemost"},{"key":"3744_CR79","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","volume":"12","author":"M Huber-Lang","year":"2006","unstructured":"Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12:682\u2013687","journal-title":"Nat Med"},{"key":"3744_CR80","first-page":"71","volume":"632","author":"U Amara","year":"2008","unstructured":"Amara U, Rittirsch D, Flierl M, Bruckner U, Klos A, Gebhard F, Lambris JD, Huber-Lang M (2008) Interaction between the coagulation and complement system. Adv Exp Med Biol 632:71\u201379","journal-title":"Adv Exp Med Biol"},{"key":"3744_CR81","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","volume":"185","author":"U Amara","year":"2010","unstructured":"Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B, Bruckner UB, Nilsson B, Gebhard F, Lambris JD, Huber-Lang M (2010) Molecular intercommunication between the complement and coagulation systems. J Immunol 185:5628\u20135636","journal-title":"J Immunol"},{"key":"3744_CR82","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00467-011-1923-9","volume":"26","author":"PF Zipfel","year":"2011","unstructured":"Zipfel PF, Wolf G, John U, Kentouche K, Skerka C (2011) Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura? Pediatr Nephrol 26:1947\u20131956","journal-title":"Pediatr Nephrol"},{"key":"3744_CR83","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","volume":"8","author":"M Noris","year":"2012","unstructured":"Noris M, Mescia F, Remuzzi G (2012) STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 8:622\u2013633","journal-title":"Nat Rev Nephrol"},{"key":"3744_CR84","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1160\/TH04-07-0450","volume":"93","author":"MP Ruiz-Torres","year":"2005","unstructured":"Ruiz-Torres MP, Casiraghi F, Galbusera M, Macconi D, Gastoldi S, Todeschini M, Porrati F, Belotti D, Pogliani EM, Noris M, Remuzzi G (2005) Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies. Thromb Haemost 93:443\u2013452","journal-title":"Thromb Haemost"},{"key":"3744_CR85","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","volume":"10","author":"M Reti","year":"2012","unstructured":"Reti M, Farkas P, Csuka D, Razso K, Schlammadinger A, Udvardy ML, Madach K, Domjan G, Bereczki C, Reusz GS, Szabo AJ, Prohaszka Z (2012) Complement activation in thrombotic thrombocytopenic purpura. J Thromb Haemost 10:791\u2013798","journal-title":"J Thromb Haemost"},{"key":"3744_CR86","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/jth.12369","volume":"11","author":"TC Wu","year":"2013","unstructured":"Wu TC, Yang S, Haven S, Holers VM, Lundberg AS, Wu H, Cataland SR (2013) Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura. J Thromb Haemost 11:1925\u20131927","journal-title":"J Thromb Haemost"},{"key":"3744_CR87","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2013-03-492421","volume":"122","author":"S Feng","year":"2013","unstructured":"Feng S, Eyler SJ, Zhang Y, Maga T, Nester CM, Kroll MH, Smith RJ, Afshar-Kharghan V (2013) Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood 122:1487\u20131493","journal-title":"Blood"},{"key":"3744_CR88","doi-asserted-by":"crossref","first-page":"e59372","DOI":"10.1371\/journal.pone.0059372","volume":"8","author":"NA Turner","year":"2013","unstructured":"Turner NA, Moake J (2013) Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis. PLoS One 8:e59372","journal-title":"PLoS One"},{"key":"3744_CR89","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.1301221","volume":"191","author":"R Tati","year":"2013","unstructured":"Tati R, Kristoffersson AC, Stahl AL, Rebetz J, Wang L, Licht C, Motto D, Karpman D (2013) Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy. J Immunol 191:2184\u20132193","journal-title":"J Immunol"},{"key":"3744_CR90","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0034-1383547","volume":"40","author":"N Turner","year":"2014","unstructured":"Turner N, Nolasco L, Nolasco J, Sartain S, Moake J (2014) Thrombotic Microangiopathies and the linkage between von Willebrand factor and the alternative complement pathway. Semin Thromb Hemost 40:544\u2013550","journal-title":"Semin Thromb Hemost"},{"key":"3744_CR91","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1161\/ATVBAHA.113.302280","volume":"33","author":"L Nolasco","year":"2013","unstructured":"Nolasco L, Nolasco J, Feng S, Afshar-Kharghan V, Moake J (2013) Human complement factor H is a reductase for large soluble von Willebrand factor multimers\u2014brief report. Arterioscler Thromb Vasc Biol 33:2524\u20132528","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3744_CR92","doi-asserted-by":"crossref","first-page":"e73715","DOI":"10.1371\/journal.pone.0073715","volume":"8","author":"S Feng","year":"2013","unstructured":"Feng S, Liang X, Cruz MA, Vu H, Zhou Z, Pemmaraju N, Dong JF, Kroll MH, Afshar-Kharghan V (2013) The interaction between factor H and von Willebrand factor. PLoS One 8:e73715","journal-title":"PLoS One"},{"key":"3744_CR93","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2013-04-495853","volume":"123","author":"J Rayes","year":"2014","unstructured":"Rayes J, Roumenina LT, Dimitrov JD, Repesse Y, Ing M, Christophe O, Jokiranta TS, Halbwachs-Mecarelli L, Borel-Derlon A, Kaveri SV, Fremeaux-Bacchi V, Lacroix-Desmazes S (2014) The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status. Blood 123:121\u2013125","journal-title":"Blood"},{"key":"3744_CR94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.kint.2016.03.023","volume":"90","author":"DG Noone","year":"2016","unstructured":"Noone DG, Riedl M, Pluthero FG, Bowman ML, Liszewski MK, Lu L, Quan Y, Balgobin S, Schneppenheim R, Schneppenheim S, Budde U, James P, Atkinson JP, Palaniyar N, Kahr WH, Licht C (2016) Von Willebrand factor regulates complement on endothelial cells. Kidney Int 90:123\u2013134","journal-title":"Kidney Int"},{"key":"3744_CR95","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/nprot.2012.093","volume":"7","author":"J Martin-Ramirez","year":"2012","unstructured":"Martin-Ramirez J, Hofman M, van den Biggelaar M, Hebbel RP, Voorberg J (2012) Establishment of outgrowth endothelial cells from peripheral blood. Nat Protoc 7:1709\u20131715","journal-title":"Nat Protoc"},{"key":"3744_CR96","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2009-12-261131","volume":"116","author":"M Othman","year":"2010","unstructured":"Othman M, Chirinian Y, Brown C, Notley C, Hickson N, Hampshire D, Buckley S, Waddington S, Parker AL, Baker A, James P, Lillicrap D (2010) Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease. Blood 116:3645\u20133652","journal-title":"Blood"},{"key":"3744_CR97","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2012-06-434373","volume":"121","author":"JW Wang","year":"2013","unstructured":"Wang JW, Bouwens EA, Pintao MC, Voorberg J, Safdar H, Valentijn KM, de Boer HC, Mertens K, Reitsma PH, Eikenboom J (2013) Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease. Blood 121:2762\u20132772","journal-title":"Blood"},{"key":"3744_CR98","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.169.8.4620","volume":"169","author":"S Nakashima","year":"2002","unstructured":"Nakashima S, Qian Z, Rahimi S, Wasowska BA, Baldwin WM 3rd (2002) Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection. J Immunol 169:4620\u20134627","journal-title":"J Immunol"},{"key":"3744_CR99","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.TP.0000146195.76904.D3","volume":"79","author":"H Ota","year":"2005","unstructured":"Ota H, Fox-Talbot K, Hu W, Qian Z, Sanfilippo F, Hruban RH, Baldwin WM 3rd (2005) Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts. Transplantation 79:276\u2013281","journal-title":"Transplantation"},{"key":"3744_CR100","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1016\/S0021-9258(18)81901-9","volume":"264","author":"R Hattori","year":"1989","unstructured":"Hattori R, Hamilton KK, McEver RP, Sims PJ (1989) Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 264:9053\u20139060","journal-title":"J Biol Chem"},{"key":"3744_CR101","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird WC (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100:158\u2013173","journal-title":"Circ Res"},{"key":"3744_CR102","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird WC (2007) Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100:174\u2013190","journal-title":"Circ Res"},{"key":"3744_CR103","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1272\/jnms.67.118","volume":"67","author":"O Kawanami","year":"2000","unstructured":"Kawanami O, Jin E, Ghazizadeh M, Fujiwara M, Jiang L, Nagashima M, Shimizu H, Takemura T, Ohaki Y, Arai S, Gomibuchi M, Takeda K, Yu ZX, Ferrans VJ (2000) Heterogeneous distribution of thrombomodulin and von Willebrand factor in endothelial cells in the human pulmonary microvessels. J Nippon Med Sch 67:118\u2013125","journal-title":"J Nippon Med Sch"},{"key":"3744_CR104","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1159\/000066471","volume":"69","author":"AM Muller","year":"2002","unstructured":"Muller AM, Skrzynski C, Skipka G, Muller KM (2002) Expression of von Willebrand factor by human pulmonary endothelial cells in vivo. Respiration 69:526\u2013533","journal-title":"Respiration"},{"key":"3744_CR105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1369\/jhc.4A6514.2005","volume":"54","author":"MP Pusztaszeri","year":"2006","unstructured":"Pusztaszeri MP, Seelentag W, Bosman FT (2006) Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385\u2013395","journal-title":"J Histochem Cytochem"},{"key":"3744_CR106","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1182\/blood-2014-11-551580","volume":"125","author":"FA Sayani","year":"2015","unstructured":"Sayani FA, Abrams CS (2015) How I treat refractory thrombotic thrombocytopenic purpura. Blood 125:3860\u20133867","journal-title":"Blood"},{"key":"3744_CR107","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00277-016-2804-x","volume":"95","author":"AE Eskazan","year":"2016","unstructured":"Eskazan AE (2016) Bortezomib therapy in patients with relapsed\/refractory acquired thrombotic thrombocytopenic purpura. Ann Hematol 95:1751\u20131756","journal-title":"Ann Hematol"},{"key":"3744_CR108","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/ATVBAHA.115.306014","volume":"35","author":"C Tersteeg","year":"2015","unstructured":"Tersteeg C, Schiviz A, De Meyer SF, Plaimauer B, Scheiflinger F, Rottensteiner H, Vanhoorelbeke K (2015) Potential for recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol 35:2336\u20132342","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3744_CR109","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2011-09-380535","volume":"119","author":"A Schiviz","year":"2012","unstructured":"Schiviz A, Wuersch K, Piskernik C, Dietrich B, Hoellriegl W, Rottensteiner H, Scheiflinger F, Schwarz HP, Muchitsch EM (2012) A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13. Blood 119:6128\u20136135","journal-title":"Blood"},{"key":"3744_CR110","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.113.006727","volume":"129","author":"C Tersteeg","year":"2014","unstructured":"Tersteeg C, de Maat S, De Meyer SF, Smeets MW, Barendrecht AD, Roest M, Pasterkamp G, Fijnheer R, Vanhoorelbeke K, de Groot PG, Maas C (2014) Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy. Circulation 129:1320\u20131331","journal-title":"Circulation"},{"key":"3744_CR111","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0035-1564838","volume":"42","author":"C Tersteeg","year":"2016","unstructured":"Tersteeg C, Fijnheer R, Pasterkamp G, de Groot PG, Vanhoorelbeke K, de Maat S, Maas C (2016) Keeping von Willebrand factor under control: alternatives for ADAMTS13. Semin Thromb Hemost 42:9\u201317","journal-title":"Semin Thromb Hemost"},{"key":"3744_CR112","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","volume":"25","author":"F Bu","year":"2014","unstructured":"Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ (2014) Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 25:55\u201364","journal-title":"J Am Soc Nephrol"},{"key":"3744_CR113","doi-asserted-by":"crossref","unstructured":"Chen J, Reheman A, Gushiken FC, Nolasco L, Fu X, Moake JL, Ni H, Lopez JA (2011) N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J Clin Invest 121:593\u2013603","DOI":"10.1172\/JCI41062"},{"key":"3744_CR114","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/trf.12561","volume":"54","author":"JN George","year":"2014","unstructured":"George JN, Lopez JA, Konkle BA (2014) N-acetylcysteine: an old drug, a new insight, a potentially effective treatment for thrombotic thrombocytopenic purpura. Transfusion 54:1205\u20131207","journal-title":"Transfusion"},{"key":"3744_CR115","doi-asserted-by":"crossref","first-page":"e1277","DOI":"10.1097\/MJT.0000000000000386","volume":"23","author":"G Cabanillas","year":"2016","unstructured":"Cabanillas G, Popescu-Martinez A (2016) N-acetylcysteine for relapsing thrombotic thrombocytopenic purpura: more evidence of a promising drug. Am J Ther 23:e1277\u2013e1279","journal-title":"Am J Ther"},{"key":"3744_CR116","doi-asserted-by":"crossref","unstructured":"Li GW, Rambally S, Kamboj J, Reilly S, Moake JL, Udden MM, Mims MP (2014) Treatment of refractory thrombotic thrombocytopenic purpura with N-acetylcysteine: a case report. Transfusion 54:1221\u20131224","DOI":"10.1111\/trf.12440"},{"key":"3744_CR117","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/trf.12787","volume":"54","author":"J Shortt","year":"2014","unstructured":"Shortt J, Opat SS, Wood EM (2014) N-acetylcysteine for thrombotic thrombocytopenic purpura: is a von Willebrand factor-inhibitory dose feasible in vivo? Transfusion 54:2362\u20132363","journal-title":"Transfusion"},{"key":"3744_CR118","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2012-04-420943","volume":"120","author":"F Callewaert","year":"2012","unstructured":"Callewaert F, Roodt J, Ulrichts H, Stohr T, van Rensburg WJ, Lamprecht S, Rossenu S, Priem S, Willems W, Holz JB (2012) Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura. Blood 120:3603\u20133610","journal-title":"Blood"},{"key":"3744_CR119","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","volume":"374","author":"F Peyvandi","year":"2016","unstructured":"Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knobl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D, Investigators TITAN (2016) Caplacizumab for acquired thrombotic thrombocytopenic purpura. N Engl J Med 374:511\u2013522","journal-title":"N Engl J Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3744-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3744-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3744-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T14:17:10Z","timestamp":1659277030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3744-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":119,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3744"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3744-y","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2017,7,26]]}}}